Literature DB >> 24361600

Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.

Christine L Kragh1, Amanda M Gysbers2, Edward Rockenstein3, Karen Murphy2, Glenda M Halliday2, Eliezer Masliah3, Poul Henning Jensen4.   

Abstract

Multiple system atrophy is a progressive, neurodegenerative disease characterized by parkinsonism, ataxia, autonomic dysfunction, and accumulation of α-synuclein in oligodendrocytes. To understand how α-synuclein aggregates impact oligodendroglial homeostasis, we investigated an oligodendroglial cell model of α-synuclein dependent degeneration and identified responses linked to the NF-κB transcription factor stress system. Coexpression of human α-synuclein and the oligodendroglial protein p25α increased the expression of IκBα mRNA and protein early during the degenerative process and this was dependent on both aggregation and Ser129 phosphorylation of α-synuclein. This response was prodegenerative because blocking IκBα expression by siRNA rescued the cells. IκBα is an inhibitor of NF-κB and acts by binding and retaining NF-κB p65 in the cytoplasm. The protection obtained by silencing IκBα was accompanied by a strong increase in nuclear p65 translocation indicating that NF-κB activation protects against α-synuclein aggregate stress. In the cellular model, two different phenotypes were observed; degenerating cells retracting their microtubules and resilient cells tolerating the coexpression of α-synuclein and p25α. The resilient cells displayed a significant higher nuclear translocation of p65 and activation of the NF-κB system relied on stress elicited by aggregated and Ser129 phosphorylated α-synuclein. To validate the relationship between oligodendroglial α-synuclein expression and IκBα, we analyzed two different lines of transgenic mice expressing human α-synuclein under the control of the oligodendrocytic MBP promotor (intermediate-expresser line 1 and high-expresser line 29). IκBα mRNA expression was increased in both lines and immunofluorescence microscopy and in situ hybridization revealed that IκBα mRNA and protein is expressed in oligodendrocytes. IκBα mRNA expression was demonstrated prior to activation of microglia and astrocytes in line 1. Human brain tissue affected by MSA displayed increased expression of IκBα and NF-κB p65 in some oligodendrocytes containing glial cytoplasmic inclusions. Our data suggest that oligodendroglial IκBα expression and NF-κB are activated early in the course of MSA and their balance contributes to the decision of cellular demise. Favoring oligodendroglial NF-κB activation may represent a therapeutic strategy for this devastating disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IκBα; Multiple system atrophy; NF-κB; Oligodendrocytes; α-Synuclein

Mesh:

Substances:

Year:  2013        PMID: 24361600      PMCID: PMC4943925          DOI: 10.1016/j.nbd.2013.12.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  57 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies.

Authors:  T Togo; E Iseki; W Marui; H Akiyama; K Uéda; K Kosaka
Journal:  J Neurol Sci       Date:  2001-02-15       Impact factor: 3.181

3.  Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.

Authors:  Philipp J Kahle; Manuela Neumann; Laurence Ozmen; Veronika Muller; Helmut Jacobsen; Will Spooren; Babette Fuss; Barbara Mallon; Wendy B Macklin; Hideo Fujiwara; Masato Hasegawa; Takeshi Iwatsubo; Hans A Kretzschmar; Christian Haass
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

4.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

5.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

Review 6.  Nuclear factor kappa B: important transcription factor and therapeutic target.

Authors:  J I Lee; G J Burckart
Journal:  J Clin Pharmacol       Date:  1998-11       Impact factor: 3.126

7.  The expression of PARP, NF-kappa B and parvalbumin is increased in Parkinson disease.

Authors:  Judit Soós; József I Engelhardt; László Siklós; László Havas; Katalin Majtényi
Journal:  Neuroreport       Date:  2004-08-06       Impact factor: 1.837

8.  NF-kappaB prevents TNF-alpha-induced apoptosis in an oligodendrocyte cell line.

Authors:  Makoto Hamanoue; Akira Yoshioka; Toya Ohashi; Yoshikatsu Eto; Ken Takamatsu
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

Review 9.  Multiple system atrophy: a primary oligodendrogliopathy.

Authors:  Gregor K Wenning; Nadia Stefanova; Kurt A Jellinger; Werner Poewe; Michael G Schlossmacher
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

10.  SIRT2 as a Therapeutic Target for Age-Related Disorders.

Authors:  Rita Machado de Oliveira; Jana Sarkander; Aleksey G Kazantsev; Tiago Fleming Outeiro
Journal:  Front Pharmacol       Date:  2012-05-03       Impact factor: 5.810

View more
  6 in total

Review 1.  Multiple system atrophy: pathogenic mechanisms and biomarkers.

Authors:  Kurt A Jellinger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

2.  Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.

Authors:  Nelson Ferreira; Hjalte Gram; Zachary A Sorrentino; Emil Gregersen; Sissel Ida Schmidt; Lasse Reimer; Cristine Betzer; Clara Perez-Gozalbo; Marjo Beltoja; Madhu Nagaraj; Jie Wang; Jan S Nowak; Mingdong Dong; Katarina Willén; Ersoy Cholak; Kaare Bjerregaard-Andersen; Nicolas Mendez; Prakruti Rabadia; Mohammad Shahnawaz; Claudio Soto; Daniel E Otzen; Ümit Akbey; Morten Meyer; Benoit I Giasson; Marina Romero-Ramos; Poul Henning Jensen
Journal:  Acta Neuropathol       Date:  2021-05-12       Impact factor: 17.088

Review 3.  Animal models of multiple system atrophy.

Authors:  Nadia Stefanova; Gregor K Wenning
Journal:  Clin Auton Res       Date:  2015-01-14       Impact factor: 4.435

4.  Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation.

Authors:  Cristine Betzer; Louise Berkhoudt Lassen; Anders Olsen; Rikke Hahn Kofoed; Lasse Reimer; Emil Gregersen; Jin Zheng; Tito Calì; Wei-Ping Gai; Tong Chen; Arne Moeller; Marisa Brini; Yuhong Fu; Glenda Halliday; Tomasz Brudek; Susana Aznar; Bente Pakkenberg; Jens Peter Andersen; Poul Henning Jensen
Journal:  EMBO Rep       Date:  2018-03-29       Impact factor: 8.807

Review 5.  Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson's Disease and Synucleinopathies.

Authors:  Cristine Betzer; Poul Henning Jensen
Journal:  Front Neurosci       Date:  2018-11-06       Impact factor: 4.677

Review 6.  Models of multiple system atrophy.

Authors:  Diadem Ricarte; Darlene Ortiz; He-Jin Lee; Seung-Jae Lee
Journal:  Exp Mol Med       Date:  2019-11-18       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.